InsidersTradesSigma
Follow the 华润双鹤 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 华润双鹤 has published 3 reports. Market capitalisation: €17.6bn. The latest transaction was disclosed on 15 July 2024 (Purchase). Among the most active insiders: 余顺坤. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
华润双鹤是一家在中国医疗保健和制药领域运营的公司，专注于药品的研发和制造。该公司在上海证券交易所上市。